Table 4.
Type-specific prevalence in mono and multi-infections according to the H28 real-time PCR test
| HPV type distribution | Mono-infections | Multi-infections | Total | p value * |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | ||
| High-risk types (HR) | 0.277 | |||
| 16 | 3 (21.4) | 11 (78.6) | 14 (6.1) | |
| 18 | 6 (46.2) | 7 (53.9) | 13 (5.7) | |
| 26 | 1 (50.0) | 1 (50.0) | 2 (0.9) | |
| 31 | 6 (46.2) | 7 (53.9) | 13 (5.7) | |
| 33 | 7 (50.0) | 7 (50.0) | 14 (6.1) | |
| 35 | 5 (33.3) | 10 (66.7) | 15 (6.6) | |
| 39 | 1 (50.0) | 1 (50.0) | 2 (0.9) | |
| 45 | 3 (27.3) | 8 (72.7) | 11 (4.8) | |
| 51 | 4 (44.4) | 5 (55.6) | 9 (4.0) | |
| 52 | 4 (22.2) | 14 (77.8) | 18 (7.9) | |
| 53 | 5 (20.8) | 19 (79.2) | 24 (10.5) | |
| 56 | 5 (38.5) | 8 (61.5) | 13 (5.7) | |
| 58 | 4 (57.1) | 3 (42.9) | 7 (3.1) | |
| 59 | 5 (50.0) | 5 (50.0) | 10 (4.4) | |
| 66 | 2 (16.7) | 10 (83.3) | 12 (5.3) | |
| 68 | 8 (38.1) | 13 (61.9) | 21 (9.2) | |
| 69 | 0 | 2 (100.0) | 2 (0.9) | |
| 73 | 2 (10.5) | 17 (89.5) | 19 (8.3) | |
| 82 | 1 (11.1) | 8 (88.9) | 9 (4.0) | |
| All | 72 (31.6) | 156 (68.4) | 228 (100.0) | |
| Low-risk types (LR) | 0.202 | |||
| 6 | 6 (66.7) | 3 (33.3) | 9 (6.2) | |
| 11 | 0 | 2 (100.0) | 2 (1.4) | |
| 40 | 2 (13.3) | 13 (86.7) | 15 (10.3) | |
| 42 | 10 (40.0) | 15 (60.0) | 25 (17.2) | |
| 43 | 4 (30.8) | 9 (69.2) | 13 (9.0) | |
| 44 | 7 (35.0) | 13 (65.0) | 20 (13.8) | |
| 54 | 6 (21.4) | 22 (78.6) | 28 (19.3) | |
| 61 | 2 (25.0) | 6 (75.0) | 8 (5.5) | |
| 70 | 9 (36.0) | 16 (64.0) | 25 (17.2) | |
| All | 46 (31.7) | 99 (68.3) | 145 (100.0) | |
| TOTAL (HR and LR) | 118 (31.6) | 255 (68.4) | 373 (100) |
*p value Mono-infections vs. Multi-infections